Akums Drugs and Pharmaceuticals IPO vs Sanstar IPO

Comparision between Akums Drugs and Pharmaceuticals IPO and Sanstar IPO.

IPO Details

Akums Drugs and Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Sanstar IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Akums Drugs and Pharmaceuticals IPO	Sanstar IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	ICICI Securities Limited Axis Bank Limited Citigroup Global Markets India Private Limited Ambit Private Limited	Pantomath Capital Advisors Pvt Ltd
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Akums Drugs and Pharmaceuticals IPO is up to ₹1,856.74 Cr whereas the issue size of the Sanstar IPO is up to ₹510.15 Cr. The final issue price of Akums Drugs and Pharmaceuticals IPO is ₹679.00 per share and of Sanstar IPO is ₹95.00 per share.

	Akums Drugs and Pharmaceuticals IPO	Sanstar IPO
Face Value	₹2 per share	₹2 per share
Issue Price (Lower)	₹646.00 per share	₹90.00 per share
Issue Price (Upper)	₹679.00 per share	₹95.00 per share
Issue Price (Final)	₹679.00 per share	₹95.00 per share
Discount (Retail)
Discount (Employee)	₹64.00 per share
Market Lot Size	22 shares	150 shares
Fresh Issue Size	1,00,14,727 shares	4,18,00,000 shares
Fresh Issue Size (Amount)	up to ₹680.00 Cr	up to ₹397.10 Cr
OFS Issue Size	1,73,30,435 shares	1,19,00,000 shares
OFS Issue Size (Amount)	up to ₹1,176.74 Cr	up to ₹113.05 Cr
Issue Size Total	2,73,45,162 shares	5,37,00,000 shares
Issue Size Total (Amount)	up to ₹1,856.74 Cr	up to ₹510.15 Cr

IPO Timetable

Akums Drugs and Pharmaceuticals IPO opens on Jul 30, 2024, while Sanstar IPO opens on Jul 19, 2024. The closing date of Akums Drugs and Pharmaceuticals IPO and Sanstar IPO is Aug 01, 2024, and Jul 23, 2024, respectively.

	Akums Drugs and Pharmaceuticals IPO	Sanstar IPO
Anchor Bid Date	Jul 29, 2024	Jul 18, 2024
Issue Open	Jul 30, 2024	Jul 19, 2024
Issue Close	Aug 01, 2024	Jul 23, 2024
Basis Of Allotment (Tentative)	Aug 02, 2024	Jul 24, 2024
Initiation of Refunds (Tentative)	Aug 05, 2024	Jul 25, 2024
Credit of Share (Tentative)	Aug 05, 2024	Jul 25, 2024
Listing date (Tentative)	Aug 06, 2024	Jul 26, 2024
Anchor Lockin End date 1	Sep 01, 2024	Aug 23, 2024
Anchor Lockin End date 2	Oct 31, 2024	Oct 22, 2024

Financials

Akums Drugs and Pharmaceuticals IPO P/E ratio is , as compared to Sanstar IPO P/E ratio of 19.98.

Akums Drugs and Pharmaceuticals IPO

Sanstar IPO

Financial

Akums Drugs and Pharmaceuticals Limited Financial Information (Restated Consolidated)

Akums Drugs and Pharmaceuticals Limited's revenue increased by 13.81% and profit after tax (PAT) dropped by -99.19% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	3,516.37	3,266.53	3,069.05
Revenue	4,212.21	3,700.93	3,694.52
Profit After Tax	0.79	97.82	-250.87
Net Worth	709.50	717.19	621.98
Reserves and Surplus	861.01	868.70	787.79
Total Borrowing	491.56	536.97	357.95
Amount in ₹ Crore

Sanstar Limited Financial Information (Restated Consolidated)

Sanstar Limited's revenue decreased by -10.58% and profit after tax (PAT) rose by 59.71% between the financial year ending with March 31, 2024 and March 31, 2023.

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	527.57	368.35	207.45
Revenue	1,081.68	1,209.67	504.77
Profit After Tax	66.77	41.81	15.92
Net Worth	215.91	149.28	48.97
Reserves and Surplus	225.18	158.41	55.69
Total Borrowing	127.64	111.70	85.22
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

84.94%

99.77%

Promoter Shareholding (Post-Issue)

70.37%

P/E Ratio

19.98

Market Cap

₹1731.32 Cr.

ROE

0.11%%

30.92%%

ROCE

3.37%%

24.43%%

Debt/Equity

0.69

0.5

EPS

₹4.75

RoNW

-0.57%

30.92%%

Shares Offered

In the Akums Drugs and Pharmaceuticals IPO retail investors (RII) are offered 27,12,424 shares while in Sanstar IPO retail investors are offered 27,12,424 shares. Qualified institutional buyers (QIB) are offered 81,37,276 shares in Akums Drugs and Pharmaceuticals IPO and 1,07,40,000 shares in Sanstar IPO.

	Akums Drugs and Pharmaceuticals IPO	Sanstar IPO
Anchor Investor Reserveration	1,22,05,912 shares	1,61,10,000 shares
Market Maker Reserveration
QIB	81,37,276 shares	1,07,40,000 shares
NII	40,68,637 shares	80,55,000 shares
RII	27,12,424 shares	1,87,95,000 shares
Employee	2,43,902 shares	0 shares
Others
Total	1,51,62,239 shares	3,75,90,000 shares

Bids Received (Subscription)

Akums Drugs and Pharmaceuticals IPO subscribed 63.44x in total, whereas Sanstar IPO subscribed 82.99x.

	Akums Drugs and Pharmaceuticals IPO	Sanstar IPO
QIB (times)	90.09x	145.68x
NII (times)	42.10x	136.49x
Big NII (times)	47.43x	149.44x
Small NII (times)	31.45x	110.61x
RII (times)	20.80x	24.23x
Employee (times)	4.14x
Other (times)
Total (times)	63.44x	82.99x

Compare with others

Akums Drugs and Pharmaceuticals IPO	Sanstar IPO
Interarch Building Products IPO	Orient Technologies IPO
Orient Technologies IPO	Unicommerce eSolutions IPO
Unicommerce eSolutions IPO	Brainbees Solutions (Firstcry) IPO
Brainbees Solutions (Firstcry) IPO	Ceigall India IPO
Ceigall India IPO	Akums Drugs and Pharmaceuticals IPO
Sanstar IPO	Bansal Wire IPO
Bansal Wire IPO	Emcure Pharma IPO
Emcure Pharma IPO	OLA Electric IPO
OLA Electric IPO	Vraj Iron and Steel IPO
Vraj Iron and Steel IPO	Aasaan Loans IPO

Comments

Add a public comment...